N.A.R.F. coordinates multi-clinical studies testing the efficacy of NAET® treatments on various allergy-related conditions caused by food allergies, environmental and chemical sensitivities, etc. All studies are double blind clinical trials following NIH research protocol and are conducted by N.A.R.F. Research Associates.

The objective of these research studies is to document the clinical success of NAET® using scientific methods, so that the medical community and insurance companies will recognize NAET® as an effective treatment and accepted for third party reimbursement. A pilot research study for Asthma is currently underway with online Quality Metrics SF-36 questionnaire. Additional research studies planned for 2004 include Autism, Arthritis & Pain Disorders, Migraine Headaches, Fibromyalgia, Chronic Fatigue Syndrome. The costs for each multi-central designed study is estimated between $150,000 to $350,000 per study from start to completion.

N.A.R.F. funds will cover comprehensive medical diagnostic tests, laboratory analysis, treatments, SF-36 online metrics, and other administrative expenses.